Monday, December 3, 2012

• Is the Risk Worth the Reward for Biotech’s Most Volatile?at Motley Fool (Mon, Dec 3)
• Today's Market News To Trade On: 5 Stocks Moving On Newsat Seeking Alpha (Mon, Dec 3)

Sunday, December 2, 2012

• Biotech Weekly Recap: Loads Of Bullishness, 2 Giant Rallies, And Sellingat Seeking Alpha (Sun, Dec 2)

Tuesday, November 27, 2012

• Why Peregrine Popped Todayat Motley Fool (Tue, Nov 27)
• Tuesday Sector Leaders: Music & Electronics Stores, Biotechnology Stocksat Forbes (Tue, Nov 27)

Friday, November 23, 2012

• [video] The Next Big Thing in Biotech: Worst CEO Candidatesat TheStreet (Fri, Nov 23)

Wednesday, November 21, 2012

• UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Peregrine Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of November 27, 2012 to Seek a Lead Plaintiff PositionMarketwired (Wed, Nov 21)

Monday, November 19, 2012

• 4 Speculative Investments You Might Want To Considerat Seeking Alpha (Mon, Nov 19)

Thursday, November 15, 2012

• Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry's Success in 2012Marketwired (Thu, Nov 15)

Wednesday, November 14, 2012

• PEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing RuleEDGAR Online (Wed, Nov 14)
• Peregrine Pharmaceuticals Announces Receipt of Notice From NASDAQMarketwired (Wed, Nov 14)

Tuesday, November 13, 2012

• Holzer Holzer & Fistel, LLC Has Filed a Class Action Lawsuit on Behalf of Investors in Peregrine Pharmaceuticals, Inc.; Reminds Investors With Large Losses of November 27th Lead Plaintiff DeadlineMarketwired (Tue, Nov 13)

Tuesday, November 6, 2012

• Acadia Pharma Selling Stock Ahead of Key Study Resultsat TheStreet (Tue, Nov 6)
• Lieff Cabraser Reminds Peregrine Pharmaceuticals, Inc. Investors of Upcoming Deadline in Class Action LawsuitsBusiness Wire (Tue, Nov 6)

Wednesday, October 31, 2012

• New Data Support Ability of PS-Targeting Antibodies to Specifically Target Tumors and Stimulate Cancer-Fighting Immune ResponsesMarketwired (Wed, Oct 31)

Tuesday, October 30, 2012

• Lieff Cabraser Announces Class Action Lawsuits Against Peregrine Pharmaceuticals, Inc.Business Wire (Tue, Oct 30)

Friday, October 19, 2012

• FDA Currently Considering Faster Approval Process for Drugs Deemed to Offer Societal BenefitMarketwired (Fri, Oct 19)

Thursday, October 18, 2012

• ZIOP: Undisclosed FDA warning letter and Palifosfamide instability are just the beginningat Forbes (Thu, Oct 18)
• Attack of the Creeping Share Countat Motley Fool (Thu, Oct 18)
• PEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters toEDGAR Online (Thu, Oct 18)
• 5 Big Time Biotech Movers On Wednesdayat Seeking Alpha (Thu, Oct 18)

Wednesday, October 17, 2012

• Biotech's Hottest Trend -- Dilutionat Motley Fool (Wed, Oct 17)
• 2 Biotechs Get the FDA's Thumbs-Upat Motley Fool (Wed, Oct 17)
• PEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Wed, Oct 17)
• The Nasdaq Now: 'F' Grade on Revenue Outlook Causes Biggest Apollo Group Decline in Two Yearsat Minyanville (Wed, Oct 17)

Add PPHM News to My Yahoo!